Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    12047962 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study
Conditions: Inflammatory Bowel Disease;   Crohn's Disease
Intervention: Biological: Infliximab
2 Suspended Role of Capsule Endoscopy in the Evaluation of Mucosal Changes During Treatment of Patients With Active Crohn's Disease
Condition: Crohn's Disease
Intervention: Device: PillCam® SB3 capsules
3 Withdrawn Improving Treatment of Inflammatory Bowel Diseases Through Better Understanding Infliximab Drug and Antibody Levels
Conditions: Crohn's Disease;   Ulcerative Colitis
Intervention:
4 Completed Study Investigating Tailored Treatment With Infliximab for Active Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Infliximab
5 Completed Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas
Conditions: Inflammatory Bowel Disease;   Intestinal Fistula
Intervention: Drug: AST-120
6 Completed A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease
Condition: Crohn Disease
Intervention: Drug: infliximab or placebo

Indicates status has not been verified in more than two years